A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare

Maria Ribeiro Da Cunha; Inês Coelho Rodrigues; Frederico Trigueiros; Luís Carlos Freitas; Sandra Braz; Fábio Cota Medeiros

Journal ArticleOPEN ACCESS

A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare

Da Cunha M
Rodrigues I
Trigueiros F
et al.

Open Forum Infectious Diseases (2021) 8(4)

DOI: 10.1093/ofid/ofab100

1Citations

27Readers

Abstract

We report a case of a man with chronic hepatitis C infection treated with remdesivir for COVID-19, resulting in lowered HCV viral load, followed by a rebound after its discontinuation. Concomitant treatment with tocilizumab possibly caused loss of anti-HBs.

Author supplied keywords

COVID-19
anti-HBs
hepatitis B
hepatitis C
remdesivir

Cite

CITATION STYLE

APA

Da Cunha, M. R., Rodrigues, I. C., Trigueiros, F., Freitas, L. C., Braz, S., & Cota Medeiros, F. (2021). A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare. Open Forum Infectious Diseases, 8(4). https://doi.org/10.1093/ofid/ofab100

A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a hepatitis C-Coinfected patient resulting in temporary viral control and posttreatment flare

Abstract

Author supplied keywords

Cite

Register to see more suggestions